X-13319571-T-C

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2

The NM_001135995.2(ATXN3L):ā€‹c.364A>Gā€‹(p.Thr122Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000091 in 1,208,631 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000045 ( 0 hom., 0 hem., cov: 23)
Exomes š‘“: 0.0000055 ( 0 hom. 4 hem. )

Consequence

ATXN3L
NM_001135995.2 missense

Scores

3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.684
Variant links:
Genes affected
ATXN3L (HGNC:24173): (ataxin 3 like) This intronless gene may be a pseudogene (PMID:11450850). This gene is similar to the multi-exon gene which encodes ataxin 3 and contains a coding region which could encode a protein similar to ataxin 3. Mutations in the gene encoding ataxin 3 are associated with Machado-Joseph disease. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.28896356).
BS2
High Hemizygotes in GnomAdExome4 at 4 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATXN3LNM_001135995.2 linkuse as main transcriptc.364A>G p.Thr122Ala missense_variant 1/1 ENST00000380622.5 NP_001129467.1 Q9H3M9B4DYC7
ATXN3LNM_001387036.1 linkuse as main transcriptc.234+130A>G intron_variant NP_001373965.1
GS1-600G8.3NR_046087.1 linkuse as main transcriptn.1935-48T>C intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATXN3LENST00000380622.5 linkuse as main transcriptc.364A>G p.Thr122Ala missense_variant 1/16 NM_001135995.2 ENSP00000369996.2 Q9H3M9
GS1-600G8.3ENST00000431486.1 linkuse as main transcriptn.1935-48T>C intron_variant 1

Frequencies

GnomAD3 genomes
AF:
0.0000445
AC:
5
AN:
112302
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34446
show subpopulations
Gnomad AFR
AF:
0.000162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000166
AC:
3
AN:
180885
Hom.:
0
AF XY:
0.0000150
AC XY:
1
AN XY:
66889
show subpopulations
Gnomad AFR exome
AF:
0.000162
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000124
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000547
AC:
6
AN:
1096329
Hom.:
0
Cov.:
31
AF XY:
0.0000111
AC XY:
4
AN XY:
361763
show subpopulations
Gnomad4 AFR exome
AF:
0.000114
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000357
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000445
AC:
5
AN:
112302
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34446
show subpopulations
Gnomad4 AFR
AF:
0.000162
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.0000907
ESP6500AA
AF:
0.000381
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000497
AC:
6
EpiCase
AF:
0.000218
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 10, 2023The c.364A>G (p.T122A) alteration is located in exon 1 (coding exon 1) of the ATXN3L gene. This alteration results from a A to G substitution at nucleotide position 364, causing the threonine (T) at amino acid position 122 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
16
DANN
Benign
0.95
DEOGEN2
Benign
0.092
T
FATHMM_MKL
Benign
0.66
D
LIST_S2
Uncertain
0.96
D
M_CAP
Benign
0.0073
T
MetaRNN
Benign
0.29
T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
1.4
L
PrimateAI
Benign
0.37
T
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.23
Sift
Benign
0.080
T
Sift4G
Uncertain
0.0040
D
Polyphen
0.28
B
Vest4
0.30
MVP
0.48
MPC
0.20
ClinPred
0.26
T
GERP RS
0.94
Varity_R
0.49
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375597318; hg19: chrX-13337690; API